Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE4.7800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.5000/ 14
- Ask / Lots5.0500/ 1
- Open / Previous Close0.0000 / 4.7800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 22901 | 4.775 |
| 09:34 ET | 1825 | 4.735 |
| 09:36 ET | 15692 | 4.78 |
| 09:38 ET | 2673 | 4.775 |
| 09:39 ET | 2649 | 4.77 |
| 09:41 ET | 8822 | 4.765 |
| 09:43 ET | 910 | 4.75 |
| 09:45 ET | 2992 | 4.7212 |
| 09:48 ET | 4350 | 4.76 |
| 09:50 ET | 2400 | 4.78 |
| 09:52 ET | 5479 | 4.8 |
| 09:54 ET | 5100 | 4.81 |
| 09:56 ET | 9026 | 4.83 |
| 09:57 ET | 6443 | 4.81 |
| 09:59 ET | 2000 | 4.78 |
| 10:01 ET | 500 | 4.79 |
| 10:03 ET | 3255 | 4.79 |
| 10:06 ET | 2570 | 4.815 |
| 10:08 ET | 6925 | 4.835 |
| 10:10 ET | 9523 | 4.845 |
| 10:12 ET | 100 | 4.845 |
| 10:14 ET | 4086 | 4.835 |
| 10:15 ET | 725 | 4.835 |
| 10:17 ET | 10372 | 4.835 |
| 10:19 ET | 8442 | 4.84 |
| 10:21 ET | 10649 | 4.845 |
| 10:24 ET | 3967 | 4.835 |
| 10:26 ET | 22383 | 4.79 |
| 10:28 ET | 5759 | 4.79 |
| 10:30 ET | 9806 | 4.79 |
| 10:32 ET | 3641 | 4.795 |
| 10:33 ET | 3581 | 4.805 |
| 10:35 ET | 9429 | 4.775 |
| 10:37 ET | 1200 | 4.78 |
| 10:39 ET | 2008 | 4.785 |
| 10:42 ET | 5321 | 4.76 |
| 10:44 ET | 700 | 4.755 |
| 10:46 ET | 3050 | 4.765 |
| 10:48 ET | 1938 | 4.765 |
| 10:50 ET | 1526 | 4.755 |
| 10:51 ET | 800 | 4.76 |
| 10:53 ET | 4465 | 4.72 |
| 10:55 ET | 1745 | 4.735 |
| 10:57 ET | 3503 | 4.74 |
| 11:00 ET | 1550 | 4.7363 |
| 11:02 ET | 437 | 4.73 |
| 11:04 ET | 2892 | 4.735 |
| 11:06 ET | 277 | 4.73 |
| 11:08 ET | 9768 | 4.7 |
| 11:09 ET | 6062 | 4.7 |
| 11:11 ET | 1314 | 4.6901 |
| 11:13 ET | 12454 | 4.675 |
| 11:15 ET | 1007 | 4.685 |
| 11:18 ET | 2202 | 4.695 |
| 11:20 ET | 3500 | 4.7 |
| 11:22 ET | 400 | 4.69 |
| 11:24 ET | 2739 | 4.69 |
| 11:26 ET | 753 | 4.69 |
| 11:27 ET | 419 | 4.69 |
| 11:29 ET | 1851 | 4.7 |
| 11:31 ET | 2380 | 4.7 |
| 11:33 ET | 4000 | 4.705 |
| 11:36 ET | 3628 | 4.71 |
| 11:38 ET | 2774 | 4.72 |
| 11:40 ET | 1200 | 4.715 |
| 11:42 ET | 286 | 4.715 |
| 11:44 ET | 990 | 4.705 |
| 11:45 ET | 3575 | 4.7 |
| 11:47 ET | 300 | 4.705 |
| 11:49 ET | 832 | 4.705 |
| 11:51 ET | 11170 | 4.725 |
| 11:54 ET | 200 | 4.7275 |
| 11:56 ET | 2288 | 4.725 |
| 11:58 ET | 344 | 4.725 |
| 12:02 ET | 9940 | 4.72 |
| 12:03 ET | 2336 | 4.735 |
| 12:05 ET | 800 | 4.735 |
| 12:07 ET | 3500 | 4.735 |
| 12:09 ET | 1266 | 4.72 |
| 12:12 ET | 2841 | 4.735 |
| 12:14 ET | 7251 | 4.745 |
| 12:16 ET | 7261 | 4.745 |
| 12:18 ET | 8698 | 4.745 |
| 12:20 ET | 1100 | 4.735 |
| 12:21 ET | 298 | 4.735 |
| 12:23 ET | 200 | 4.735 |
| 12:25 ET | 800 | 4.73 |
| 12:30 ET | 1200 | 4.715 |
| 12:32 ET | 3009 | 4.71 |
| 12:34 ET | 100 | 4.71 |
| 12:36 ET | 700 | 4.72 |
| 12:38 ET | 614 | 4.7175 |
| 12:39 ET | 701 | 4.715 |
| 12:41 ET | 3354 | 4.73 |
| 12:43 ET | 9052 | 4.735 |
| 12:48 ET | 1179 | 4.745 |
| 12:50 ET | 900 | 4.745 |
| 12:52 ET | 1841 | 4.74 |
| 12:54 ET | 24144 | 4.775 |
| 12:56 ET | 3476 | 4.79 |
| 12:57 ET | 6694 | 4.805 |
| 12:59 ET | 300 | 4.81 |
| 01:01 ET | 6438 | 4.8259 |
| 01:03 ET | 2293 | 4.825 |
| 01:06 ET | 100 | 4.83 |
| 01:08 ET | 1195 | 4.835 |
| 01:10 ET | 5800 | 4.825 |
| 01:14 ET | 1100 | 4.825 |
| 01:15 ET | 5303 | 4.83 |
| 01:17 ET | 2404 | 4.835 |
| 01:19 ET | 2300 | 4.831 |
| 01:24 ET | 2283 | 4.845 |
| 01:26 ET | 3097 | 4.8593 |
| 01:28 ET | 3064 | 4.86 |
| 01:30 ET | 2883 | 4.87 |
| 01:32 ET | 400 | 4.865 |
| 01:35 ET | 1231 | 4.86 |
| 01:39 ET | 450 | 4.86 |
| 01:42 ET | 200 | 4.87 |
| 01:46 ET | 3110 | 4.875 |
| 01:48 ET | 1356 | 4.875 |
| 01:50 ET | 1060 | 4.89 |
| 01:51 ET | 600 | 4.895 |
| 01:53 ET | 4862 | 4.91 |
| 01:55 ET | 200 | 4.905 |
| 01:57 ET | 1255 | 4.895 |
| 02:02 ET | 3520 | 4.9 |
| 02:04 ET | 362 | 4.8912 |
| 02:06 ET | 300 | 4.9 |
| 02:09 ET | 400 | 4.89 |
| 02:11 ET | 900 | 4.895 |
| 02:13 ET | 6081 | 4.92 |
| 02:15 ET | 415 | 4.92 |
| 02:18 ET | 400 | 4.92 |
| 02:20 ET | 300 | 4.92 |
| 02:22 ET | 100 | 4.92 |
| 02:24 ET | 200 | 4.915 |
| 02:26 ET | 400 | 4.92 |
| 02:27 ET | 200 | 4.915 |
| 02:29 ET | 200 | 4.92 |
| 02:31 ET | 2144 | 4.91 |
| 02:33 ET | 1896 | 4.905 |
| 02:36 ET | 200 | 4.905 |
| 02:38 ET | 1300 | 4.9 |
| 02:40 ET | 6730 | 4.895 |
| 02:42 ET | 10480 | 4.875 |
| 02:44 ET | 100 | 4.88 |
| 02:45 ET | 400 | 4.875 |
| 02:47 ET | 200 | 4.875 |
| 02:49 ET | 2777 | 4.865 |
| 02:51 ET | 400 | 4.865 |
| 02:54 ET | 13776 | 4.875 |
| 02:56 ET | 1636 | 4.865 |
| 02:58 ET | 916 | 4.865 |
| 03:00 ET | 200 | 4.87 |
| 03:02 ET | 400 | 4.865 |
| 03:03 ET | 600 | 4.865 |
| 03:05 ET | 700 | 4.865 |
| 03:07 ET | 400 | 4.86 |
| 03:09 ET | 3171 | 4.85 |
| 03:12 ET | 4283 | 4.845 |
| 03:14 ET | 926 | 4.84 |
| 03:16 ET | 300 | 4.845 |
| 03:18 ET | 200 | 4.84 |
| 03:20 ET | 2533 | 4.845 |
| 03:21 ET | 5546 | 4.8294 |
| 03:23 ET | 1269 | 4.825 |
| 03:25 ET | 300 | 4.825 |
| 03:27 ET | 800 | 4.825 |
| 03:30 ET | 300 | 4.8275 |
| 03:32 ET | 8116 | 4.83 |
| 03:34 ET | 492 | 4.83 |
| 03:36 ET | 6833 | 4.815 |
| 03:38 ET | 2534 | 4.815 |
| 03:39 ET | 15112 | 4.8203 |
| 03:41 ET | 38970 | 4.8 |
| 03:43 ET | 5123 | 4.805 |
| 03:45 ET | 4473 | 4.795 |
| 03:48 ET | 11838 | 4.805 |
| 03:50 ET | 4061 | 4.79 |
| 03:52 ET | 10438 | 4.785 |
| 03:54 ET | 2645 | 4.78 |
| 03:56 ET | 11824 | 4.76 |
| 03:57 ET | 23092 | 4.775 |
| 03:59 ET | 33208 | 4.78 |
Yesterday
Apr 3, 2024
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference, from 8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 2, 2024
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4), from 4:01PM ET on Tuesday Apr 02, 2024 by Dow Jones
4:01PM ET on Tuesday Apr 02, 2024 by Dow Jones
Mar 28, 2024
DJ Fate Therapeutics Is Maintained at Underperform by B of A Securities, from 2:24PM ET on Thursday Mar 28, 2024 by Dow Jones
2:24PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 541.0M | -2.9x | --- |
CureVac NV | 566.5M | -1.7x | --- |
Zymeworks Inc | 614.6M | -5.0x | --- |
Urogen Pharma Ltd | 490.3M | -3.9x | --- |
Editas Medicine Inc | 460.5M | -2.7x | --- |
OmniAb Inc | 548.1M | -9.4x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- General Counsel and Corporate Secretary
- Cindy Tahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $541.0M |
|---|---|
Revenue (TTM) | $63.5M |
Shares Outstanding | 113.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.77 |
EPS | $-1.63 |
Book Value | $3.74 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | 8.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -299.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
